NL8921278A - Nieuw cyclobutaanderivaat en werkwijze voor het bereiden ervan. - Google Patents

Nieuw cyclobutaanderivaat en werkwijze voor het bereiden ervan. Download PDF

Info

Publication number
NL8921278A
NL8921278A NL8921278A NL8921278A NL8921278A NL 8921278 A NL8921278 A NL 8921278A NL 8921278 A NL8921278 A NL 8921278A NL 8921278 A NL8921278 A NL 8921278A NL 8921278 A NL8921278 A NL 8921278A
Authority
NL
Netherlands
Prior art keywords
bis
group
compound
hydroxymethyl
general formula
Prior art date
Application number
NL8921278A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nippon Kayaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kk filed Critical Nippon Kayaku Kk
Publication of NL8921278A publication Critical patent/NL8921278A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NL8921278A 1988-11-22 1989-11-22 Nieuw cyclobutaanderivaat en werkwijze voor het bereiden ervan. NL8921278A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP29513588 1988-11-22
JP29513588 1988-11-22
JP4303689 1989-02-27
JP4303689 1989-02-27
JP15822389 1989-06-22
JP15822389 1989-06-22

Publications (1)

Publication Number Publication Date
NL8921278A true NL8921278A (nl) 1990-10-01

Family

ID=27291425

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8921278A NL8921278A (nl) 1988-11-22 1989-11-22 Nieuw cyclobutaanderivaat en werkwijze voor het bereiden ervan.

Country Status (5)

Country Link
ES (1) ES2049678A6 (sv)
GB (1) GB2232669B (sv)
NL (1) NL8921278A (sv)
SE (1) SE501370C2 (sv)
WO (1) WO1990005730A2 (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
AU622926B2 (en) * 1988-09-09 1992-04-30 Nippon Kayaku Kabushiki Kaisha Pyrimidine or purine cyclobutane derivatives

Also Published As

Publication number Publication date
GB2232669B (en) 1992-11-25
ES2049678A6 (es) 1994-04-16
GB9015942D0 (en) 1990-09-05
WO1990005730A3 (en) 1990-09-07
SE9002445L (sv) 1990-07-16
SE9002445D0 (sv) 1990-07-16
GB2232669A (en) 1990-12-19
SE501370C2 (sv) 1995-01-23
WO1990005730A2 (en) 1990-05-31

Similar Documents

Publication Publication Date Title
EP0358154B1 (en) Novel cyclobutane derivative and process for producing same
US5059690A (en) Purinyl tetrahydrofurans
US6573378B1 (en) Antiviral guanine derivatives
JP3519736B2 (ja) エナンチオマー的に純粋なβ‐D‐ジオキソラン−ヌクレオシド
FI90422C (sv) Förfarande för framställning av nya terapeutiskt användbara purinyl- och pyrimidinylcyklobutanderivat
CZ193489A3 (en) Bis(hydroxymethyl)cyclobutyl purines and pyrimidines, process of their preparation and use
Zhao et al. Asymmetric synthesis of (1'S, 2'R)-cyclopropyl carbocyclic nucleosides
KR100232619B1 (ko) 사이클로프로판 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
DK166823B1 (da) Purinforbindelser, fremgangsmaade til fremstilling heraf, samt anvendelse af forbindelserne som farmaceutika
EP0394893B1 (en) Purinyl and pyrimidinyl tetrahydrofurans
NL8921278A (nl) Nieuw cyclobutaanderivaat en werkwijze voor het bereiden ervan.
US5374625A (en) Adenine and guanine derivatives for the treatment of hepatitis virus infections
EP0330992A2 (en) Novel cyclobutane Derivatives, processes for their preparation and pharmaceutical compositions comprising them
JP2577640B2 (ja) 新規なシクロブタン誘導体
JP2632646B2 (ja) 新規なシクロブタン誘導体及びその製造法
JPH07126282A (ja) 新規なチオヌクレオシド誘導体
JP3072600B2 (ja) 新規化合物、その製法及びそれを含む医薬組成物
JP2783531B2 (ja) 制癌剤
US5145960A (en) Pyrimidinyl tetrahydrofurans
JP2888333B2 (ja) 抗ウイルス剤
US5272152A (en) Purinyl and pyrimidinyl tetrahydrofurans
EP0464769A2 (en) Purinyl and pyrimidinyl tetrahydrofurans
US5164520A (en) Intermediates for purinyl and pyrimidinyl tetrahydrofurans
JPH03223264A (ja) 新規なシクロペンタン誘導体及びその製造法
JPH051044A (ja) 新規な核酸誘導体及びその製造法

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed